Cargando…

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents

OBJECTIVE: To characterize the extent of retention and biodistribution of gadolinium (Gd) following intra-articular (IA) injection of linear and macrocyclic gadolinium-based contrast agents (GBCAs) into the knee joint of a rat model. MATERIALS AND METHODS: Fifteen Wistar rats were divided into five...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ringler, Michael D., Rhodes, Nicholas G., Ayers-Ringler, Jennifer R., Jakaitis, Daniel R., McDonald, Robert J., Kallmes, David F., McDonald, Jennifer S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119273/ https://www.ncbi.nlm.nih.gov/pubmed/33404669 http://dx.doi.org/10.1007/s00256-020-03695-3

Ejemplares similares

Gadolinium-based contrast agents for imaging of the central nervous system: A multicenter European prospective study
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2022)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker γH2AX
por: McDonald, Jennifer S., et al.
Publicado: (2018)

Correction: Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker γH2AX
por: McDonald, Jennifer S., et al.
Publicado: (2018)

Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents
por: Strzeminska, Izabela, et al.
Publicado: (2020)

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
por: Lohrke, Jessica, et al.
Publicado: (2017)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Hypersensitivity to Gadolinium-Based Contrast Media
por: Gracia Bara, M. Teresa, et al.
Publicado: (2022)

Fatal Allergic Reaction to Gadolinium Contrast
por: Chalise, Som N, et al.
Publicado: (2023)

Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2017)

Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
por: Bussi, Simona, et al.
Publicado: (2020)

Gadolinium Retention after Contrast-Enhanced Magnetic Resonance Imaging: A Narratative Review
por: Al-Muhanna, Afnan Fahd
Publicado: (2022)

Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats
por: Frenzel, Thomas, et al.
Publicado: (2017)

Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats
por: Jost, Gregor, et al.
Publicado: (2019)

Prospective multicenter assessment of patient preferences for properties of gadolinium-based contrast media and their potential socioeconomic impact in a screening breast MRI setting
por: Woolen, Sean A., et al.
Publicado: (2021)

Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study
por: Messina, Carmelo, et al.
Publicado: (2019)

Renal Safety of Repeated Intravascular Administrations of Iodinated or Gadolinium-Based Contrast Media within a Short Interval
por: Kwon, Chiheon, et al.
Publicado: (2021)

Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
por: Davies, Julie, et al.
Publicado: (2022)

Gadolinium in human brain sections and colocalization with other elements
por: El-Khatib, Ahmed H., et al.
Publicado: (2018)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Gadolinium-based Contrast Media, Cerebrospinal Fluid and the Glymphatic System: Possible Mechanisms for the Deposition of Gadolinium in the Brain
por: Taoka, Toshiaki, et al.
Publicado: (2018)

Proteomic Analysis of Cardioembolic and Large Artery Atherosclerotic Clots Using Reverse Phase Protein Array Technology Reveals Key Cellular Interactions Within Clot Microenvironments
por: Abbasi, Mehdi, et al.
Publicado: (2021)

Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain
por: Anderhalten, Lina, et al.
Publicado: (2022)

Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation
por: Weinreb, Jeffrey C., et al.
Publicado: (2020)

T(1) Shortening in the Cerebral Cortex after Multiple Administrations of Gadolinium-based Contrast Agents
por: Khant, Zaw Aung, et al.
Publicado: (2016)

An initial investigation of serum cytokine levels in patients with gadolinium retention
por: Maecker, Holden T., et al.
Publicado: (2020)

Gadolinium Retention as a Safety Signal: Experience of a Manufacturer
por: Lancelot, Eric, et al.
Publicado: (2020)

Erroneous intra-articular injection of gadolinium solution at 0.5 mol/l concentration: a case report
por: Genovese, Eugenio A, et al.
Publicado: (2009)

Intra-articular angioleiomyoma of the knee with an atypical finding on gadolinium-enhanced magnetic resonance imaging: a case report
por: Fukawa, Taisuke, et al.
Publicado: (2014)

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Analytical Interference in Serum Iron Determination Reveals Iron Versus Gadolinium Transmetallation With Linear Gadolinium-Based Contrast Agents
por: Fretellier, Nathalie, et al.
Publicado: (2014)

Changes in Urinary and Serum Levels of Novel Biomarkers after Administration of Gadolinium-based Contrast Agents
por: Mawad, Habib, et al.
Publicado: (2016)

Acute respiratory distress syndrome following administration of gadolinium contrast agent: a case report
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

Accuracy of MR arthrography in the detection of posterior glenoid labral injuries of the shoulder
por: Rixey, Allison, et al.
Publicado: (2022)

Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection
por: Lu, Rong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2uivm0vtnhp8bol0otinf75soh